Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Remifentanil
Locations
1
China
the Affiliated Hospital of Yangzhou University
Yangzhou, Jiangsu, China
Start Date
December 18, 2021
Primary Completion Date
March 30, 2022
Completion Date
March 30, 2022
Last Updated
February 1, 2022
NCT06834113
NCT04124757
NCT05067829
Lead Sponsor
Yangzhou University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions